Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans
by
Gerra G, Zaimovic A, Moi G, Giusti F, Gardini S,
Delsignore R, Laviola G, Macchia T, Brambilla F.
Centro Studi Farmacotossicodipendenze,
Ser.T., AUSL di Parma,
Via Spalato 2, 43100, Parma, Italy
Behav Brain Res 2002 Aug 21;134(1-2):403

ABSTRACT

Twelve(+/-) 3,4-methylenedioxymethamphetamine (MDMA) users, who did not show other drug dependencies or prolonged alcohol abuse (group A), and 12 control subjects (group B) were included in the study. Prolactin (PRL) and growth hormone (GH) responses to the dopaminergic agonist bromocriptine (BROM) and psychometric measures were evaluated 3 weeks after MDMA discontinuation. PRL decreased both in A and B subjects after BROM suppression, without any significant difference between the two groups. PRL responses to BROM in MDMA users were in the normal range. In contrast, GH responses to BROM stimulation were found significantly reduced in ecstasy users, in comparison with control subjects (P<0.001; F=6.26). MDMA users showed higher scores on the Novelty Seeking (NS) scale at the Three dimensional Personality Questionnaire (TPQ), on direct aggressiveness subscale at Buss Durkee Hostility Inventory (BDHI), on subscale D (depression) at Minnesota Multiphasic Personality Inventory (MMPI 2) and on Hamilton Depression Rating Scale (HDRS) than control subjects. PRL areas under the curves (AUCs) showed a significant inverse correlation with NS scores both in A and B subjects. GH AUCs directly correlated with NS scores in healthy subjects, but not in MDMA users. No other psychometric measure correlated with hormonal responses. GH AUCs were inversely correlated with the measures of MDMA exposure (r=-0.48; P<0.01). Lower GH response to BROM in A subjects (MDMA users) could reflect reduced D2 receptor sensitivity in the hypothalamus, possibly due to increased intrasynaptic dopamine concentration. Although the hypothesis of dopaminergic changes associated with a premorbid condition cannot be completely excluded, the inverse correlation between DA receptors sensitivity and the extent of ecstasy exposure may suggest a direct pharmacological action of MDMA on brain dopamine function in humans.

Vanoxerine
MDMA/MDE
Controversies
Protect and survive
MDMA and immunity
Mesolimbic dopamine
MDMA and serotonin synthesis
MDMA, serotonin and dopamine
Potentiation of dopamine release
Haloperidol pretreatment: effects

Refs
HOME
HedWeb
BLTC Research
Empathogens.com
The Good Drug Guide
Paradise-Engineering
The Hedonistic Imperative